- DocumentoCase Discussion 1enviado porDinar Danan Sukmawati
- DocumentoKTI NUR BAB IV baruenviado porDinar Danan Sukmawati
- DocumentoSepsis and Shock Sepsisenviado porDinar Danan Sukmawati
- Documento1475-2875-10-278enviado porDinar Danan Sukmawati
- DocumentoPedoman Penatalaksana Kasus Malaria Di Indonesiaenviado porDinar Danan Sukmawati
- DocumentoStok Ranap Sep -Ok 20 Lokasi Depo Ranapenviado porDinar Danan Sukmawati
- DocumentoFormularium Spesialistik Ilmu Penyakit Dalamenviado porDinar Danan Sukmawati
- Documento1013-1920-1-SMenviado porDinar Danan Sukmawati
- DocumentoCheck List Supervisi Apotekerenviado porDinar Danan Sukmawati
- DocumentohighAlert2018-Acute-Final (2).pdfenviado porDinar Danan Sukmawati
- DocumentoCHECK LIST SUPERVISI APOTEKER.pdfenviado porDinar Danan Sukmawati
- DocumentoDaftar Regulasi Snars 1enviado porDinar Danan Sukmawati
- Documentoinsulin pharmacology therapeutic regimen and priciple of intensive insulin theraphy 2enviado porDinar Danan Sukmawati
- DocumentoEfficacy and Safety of Combination Antiplatelet Therapiesin Patients With Symptomatic IntracranialAtherosclerotic Stenosis.pdfenviado porDinar Danan Sukmawati
- Documento01-Update Standar (Dra Arofa Idha MFarm Klin Apt).pdfenviado porDinar Danan Sukmawati
- DocumentoPrevention of Gastrointestinal Bleeding in PatientsReceiving Direct Oral Anticoagulantsenviado porDinar Danan Sukmawati
- DocumentoEvaluation of a Potential Clinical Interaction betweenCeftriaxone and Calcium.pdfenviado porDinar Danan Sukmawati
- DocumentoPERANAN APOTEKER PADA TERAPI CAIRAN DAN ELEKTROLIT.pdfenviado porDinar Danan Sukmawati
- DocumentoParenteral NutritionFormulation, Monitoring,and Complicationsenviado porDinar Danan Sukmawati
- DocumentoMeds That Should Not Be Crushedenviado porDinar Danan Sukmawati
- DocumentoExpert position paper on the use of proton pumpinhibitors in patients with cardiovascular diseaseand antithrombotic therapyenviado porDinar Danan Sukmawati
- DocumentoPharmacology of Proton Pump Inhibitors.pdfenviado porDinar Danan Sukmawati